Abstract:Background: For myeloid neoplasms with t(7;11)(p15;p15) translocation, the prognosis is quite dismal. Because these tumors are rare, most occurrences are reported as single cases. Clinical results and optimal treatment approaches remain elusive. This study endeavors to elucidate the clinical implications and prognosis of this cytogenetic aberration. Methods: This study retrospectively analyzed 23 cases of myeloid neoplasm with t(7;11)(p15;p15). Clinicopathological characteristics, genetic alterations, and outcomes were evaluated, and the Kaplan-Meier method was employed to construct survival curves. Results: Of these, nine cases were newly diagnosed acute myeloid leukemia (ND AML), seven presented with relapsed refractory AML (R/R AML), four had myelodysplastic syndrome (MDS), two had secondary AML, and one exhibited a mixed germinoma associated with MDS. Patients with t(7;11)(p15;p15) in AML were primarily younger females who preferred subtype M2. Interestingly, these patients had decreased hemoglobin and red blood cell counts, along with markedly elevated levels of lactic dehydrogenase and interleukin-6, and exhibited the expression of CD117. R/R AML patients exhibited a higher likelihood of additional chromosome abnormalities (ACAs) besides t(7;11). WT1 and FLT3-ITD were the most commonly found mutated genes, and 10 of those instances showed evidence of the NUP98::HOXA9 fusion gene. The composite complete remission rate was 66.7% (12/18), while the cumulative graft survival rate was 100% (4/4). However, the survival outcomes were dismal. Interestingly, the median overall survival for R/R AML patients was 4.0 months (95% CI: 1.7-6.4). Additionally, the type of AML diagnosis or the presence of ACAs or molecular prognostic stratification did not significantly influence clinical outcomes (p = 0.066, p = 0.585, p = 0.570, respectively). Conclusion: Myeloid leukemia with t(7;11) exhibits unique clinical features, cytogenetic properties, and molecular genetic characteristics. These survival outcomes were dismal. R/R AML patients have a limited lifespan. For myeloid patients with t(7;11), targeted therapy or transplantation may be an effective course of treatment.

Clinical analysis on 15 acute myeloid leukemia patients with 11p15 abnormalities

Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 1

[Clinical and Cytogenetics Studies on Acute Myeloid Leukemia with Abnormality of Chromosome 11].

Prognosis Influence of Additional Chromosome Abnormalities in Newly Diagnosed Acute Promyelocytic Leukemia with T(15;17)(q24;q21)

[Analysis of Age-Specific Cytogenetic Changes among 515 Patients Withacute Myeloid Leukemia].

[Clinical features and prognosis of acute myeloid leukemia with acquired trisomy 21].

Clinical Analysis of 24 Cases of Acute Myeloid Leukemia with 3q Abnormalities

[Clinical and laboratory studies of 11 acute myeloid leukemia patients with t(7;11) (p15;p15) translocation].

[Analysis of 32 Cases of Acute Leukemia with Abnormality of Chromosome 7].

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

[Cytogenetic and Clinical Analysis of -7/7Q- Abnormalities in Acute Leukemia and Myelodysplastic Syndrome].

FLT3 and NPM1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Normal Cytogenetics

[Cytogenetic Analysis of 154 Case of Acute Myeloid Leukemia with T(8;21)].

Expression and Clinical Significance of ID1 Gene in Acute Myeloid Leukemia

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Karyotypic Analysis and Prognosis for 41 Patients with Chronic Myelomonocytic Leukemia

Clinical and Laboratory Studies of 17 Patients with Acute Myeloid Leukemia Harboring T(7;11)(p15;p15) Translocation

Clinical Characteristics of Acute Myeloid Leukemia with T(16;21)(p11;q22):Nine Cases Report and Literature Review

[Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].

Characteristics of 11 Patients with Acute Myeloid Leukemia Accompanied with Karyotype Aberration T(6;9)

Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study